About Biokin
Company Founder
Innovative Pharmaceutical Company Synchronizing R&D, Production and Marketing
Innovation Being Widely Recognized
Enterprise Development Planning
Company Culture
Innovation and R&D
Innovative and Efficient R&D system
SystImmune
Baili-Bio/Baili Pharmaceutical
Clinical Dynamics
Manufacturing and Quality Control
Manufacturing System
GMP standard and quality assurance
Product and Marketing
Comprehensive Marketing System
Anesthesia
Parenteral Nutrition
Anti-Infectives
Pediatrics
Traditional Chinese Medicines
Investor Relations
Corporate Governance
Announcements & Circulars
Financial Reports
ESG
Listing Documents
Company Presentations
Investor Contacts
Contact Us
EN
中文
繁体
中文
繁体
EN
中文
繁体
中文
繁体
About Biokin
Company Founder
Innovative Pharmaceutical Company Synchronizing R&D, Production and Marketing
Innovation Being Widely Recognized
Enterprise Development Planning
Company Culture
Innovation and R&D
Innovative and Efficient R&D system
SystImmune
Baili-Bio/Baili Pharmaceutical
Clinical Dynamics
Manufacturing and Quality Control
Manufacturing System
GMP standard and quality assurance
Product and Marketing
Comprehensive Marketing System
Anesthesia
Parenteral Nutrition
Anti-Infectives
Pediatrics
Traditional Chinese Medicines
Investor Relations
Corporate Governance
Announcements & Circulars
Financial Reports
ESG
Listing Documents
Company Presentations
Investor Contacts
Contact Us
Investor contacts
Home
>
Investor Relations
>
Investor Contacts
>
Investor Relations
Corporate Governance
Announcements & Circulars
Financial Reports
ESG
Listing Documents
Company Presentations
Investor Contacts
Investor contact phone number
028-85321013
Investor contact email address
ir@baili-pharm.com
Company address
No. 1, Building 1, No. 161, Baili Road, Cross-Strait Science and Technology Park, Wenjiang District, Chengdu
Submit
Submitted successfully!
Submission failed!